Autologous dendritic cells pulsed with antigen vaccine (Henan Cancer Hospital)

N/A

Report date: 2024/11/21 20:00:04

Base Information

Drug NameAutologous dendritic cells pulsed with antigen vaccine (Henan Cancer Hospital)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesHenan Provincial Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHenan Provincial Cancer Hospital

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A